Conversion to Monotherapy Study With Keppra XR for Partial Seizures

NCT00419094 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
228
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

UCB Pharma